NDC11 00597039013
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00597-0390-13 | 00597-0390 |
| 00597-390-13 | 00597-390 |
| 0597-0390-13 | 0597-0390 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trijardy XR | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 71873567-9594-452a-bb92-34a129adecac | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 0597-0390-13 0597-0390 00597039013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.